Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Feb;81(2):349–364. doi: 10.1172/JCI113327

Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.

A A Sima 1, V Nathaniel 1, V Bril 1, T A McEwen 1, D A Greene 1
PMCID: PMC329577  PMID: 3339124

Abstract

Altered sorbitol and myo-inositol metabolism, (Na,K)-ATPase function, electrochemical sodium gradients, axonal swelling, and distortion and disruption of the node of Ranvier ("axo-glial dysjunction") directly implicate hyperglycemia in the pathogenesis of neuropathy in diabetic rats, but the relevance of this sequence to clinical neuropathy in heterogeneous groups of diabetic patients remains to be established. Fascicular sural nerve morphometry in 11 patients with neuropathy complicating insulin-dependent diabetes revealed a pattern of interrelated structural changes strikingly similar to that of the diabetic rat when compared to age-matched controls. 17 older non-insulin-dependent diabetic patients with comparable duration and severity of hyperglycemia and severity of neuropathy, displayed similar nerve fiber loss, paranodal demyelination, paranodal remyelination and segmental demyelination compared to age-matched controls, but axo-glial dysjunction was replaced by Wallerian degeneration as the primary manifestation of fiber damage, and fiber loss occurred in a spatial pattern consistent with an ischemic component. The mechanistic model developed from the diabetic rat does indeed appear to apply to human diabetic neuropathy, but superimposed hormonal, metabolic, vascular, and/or age-related effects alter the morphologic expression of the neuropathy in non-insulin dependent diabetes.

Full text

PDF
349

Images in this article

357Image
on p.357
360Image
on p.360
361Image
on p.361

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arezzo J. C., Schaumburg H. H., Laudadio C. Thermal sensitivity tester. Device for quantitative assessment of thermal sense in diabetic neuropathy. Diabetes. 1986 May;35(5):590–592. doi: 10.2337/diab.35.5.590. [DOI] [PubMed] [Google Scholar]
  2. Arezzo J. C., Schaumburg H. H., Petersen C. A. Rapid screening for peripheral neuropathy: a field study with the Optacon. Neurology. 1983 May;33(5):626–629. doi: 10.1212/wnl.33.5.626. [DOI] [PubMed] [Google Scholar]
  3. Behse F., Buchthal F., Carlsen F. Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry. 1977 Nov;40(11):1072–1082. doi: 10.1136/jnnp.40.11.1072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berthold C. H., Nilsson I., Rydmark M. Axon diameter and myelin sheath thickness in nerve fibres of the ventral spinal root of the seventh lumbar nerve of the adult and developing cat. J Anat. 1983 May;136(Pt 3):483–508. [PMC free article] [PubMed] [Google Scholar]
  5. Bischoff A. Diabetische Neuropathie. PathologischeAnatomie, Pathophysiologie und Pathogenese auf Grund elektronenmikroskopischer Untersuchungen. Dtsch Med Wochenschr. 1968 Feb 9;93(6):237–passim. doi: 10.1055/s-0028-1105047. [DOI] [PubMed] [Google Scholar]
  6. Brismar T. Neuropathy-functional abnormalities in the BB rat. Metabolism. 1983 Jul;32(7 Suppl 1):112–117. doi: 10.1016/s0026-0495(83)80023-7. [DOI] [PubMed] [Google Scholar]
  7. Brismar T., Sima A. A. Changes in nodal function in nerve fibres of the spontaneously diabetic BB-Wistar rat: potential clamp analysis. Acta Physiol Scand. 1981 Dec;113(4):499–506. doi: 10.1111/j.1748-1716.1981.tb06928.x. [DOI] [PubMed] [Google Scholar]
  8. Brismar T., Sima A. A., Greene D. A. Reversible and irreversible nodal dysfunction in diabetic neuropathy. Ann Neurol. 1987 May;21(5):504–507. doi: 10.1002/ana.410210515. [DOI] [PubMed] [Google Scholar]
  9. Budzilovich G. N. Diabetic neuropathy complex. Virchows Arch A Pathol Pathol Anat. 1970;350(2):105–122. doi: 10.1007/BF00543215. [DOI] [PubMed] [Google Scholar]
  10. Chakrabarti S., Sima A. A., Nakajima T., Yagihashi S., Greene D. A. Aldose reductase in the BB rat: isolation, immunological identification and localization in the retina and peripheral nerve. Diabetologia. 1987 Apr;30(4):244–251. doi: 10.1007/BF00270423. [DOI] [PubMed] [Google Scholar]
  11. Chopra J. S., Fannin T. Pathology of diabetic neuropathy. J Pathol. 1971 Jul;104(3):175–184. doi: 10.1002/path.1711040304. [DOI] [PubMed] [Google Scholar]
  12. Chopra J. S., Hurwitz L. J., Montgomery D. A. The pathogenesis of sural nerve changes in diabetes mellitus. Brain. 1969;92(2):391–418. doi: 10.1093/brain/92.2.391. [DOI] [PubMed] [Google Scholar]
  13. Dyck P. J., Karnes J. L., O'Brien P., Okazaki H., Lais A., Engelstad J. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol. 1986 May;19(5):440–449. doi: 10.1002/ana.410190504. [DOI] [PubMed] [Google Scholar]
  14. Dyck P. J., Karnes J., O'Brien P., Nukada H., Lais A., Low P. Spatial pattern of nerve fiber abnormality indicative of pathologic mechanism. Am J Pathol. 1984 Nov;117(2):225–238. [PMC free article] [PubMed] [Google Scholar]
  15. Dyck P. J., Lais A., Karnes J. L., O'Brien P., Rizza R. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol. 1986 May;19(5):425–439. doi: 10.1002/ana.410190503. [DOI] [PubMed] [Google Scholar]
  16. Dyck P. J., Low P. A., Sparks M. F., Hexum L. A., Karnes J. L. Effect of serum hyperosmolality on morphometry of healthy human sural nerve. J Neuropathol Exp Neurol. 1980 May;39(3):285–295. doi: 10.1097/00005072-198005000-00005. [DOI] [PubMed] [Google Scholar]
  17. Dyck P. J., Sherman W. R., Hallcher L. M., Service F. J., O'Brien P. C., Grina L. A., Palumbo P. J., Swanson C. J. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol. 1980 Dec;8(6):590–596. doi: 10.1002/ana.410080608. [DOI] [PubMed] [Google Scholar]
  18. FAGERBERG S. E. Diabetic neuropathy: a clinical and histological study on the significance of vascular affections. Acta Med Scand Suppl. 1959;345:1–97. [PubMed] [Google Scholar]
  19. Green R. J., King R. H., Thomas P. K., Baron D. N. Sodium-potassium-ATPase activity in the dorsal root ganglia of rats with streptozotocin-induced diabetes. Diabetologia. 1985 Feb;28(2):104–107. doi: 10.1007/BF00279925. [DOI] [PubMed] [Google Scholar]
  20. Greene D. A., Chakrabarti S., Lattimer S. A., Sima A. A. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol. J Clin Invest. 1987 May;79(5):1479–1485. doi: 10.1172/JCI112977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Greene D. A., Lattimer S. A., Sima A. A. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med. 1987 Mar 5;316(10):599–606. doi: 10.1056/NEJM198703053161007. [DOI] [PubMed] [Google Scholar]
  22. Greene D. A., Lattimer S., Ulbrecht J., Carroll P. Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care. 1985 May-Jun;8(3):290–299. doi: 10.2337/diacare.8.3.290. [DOI] [PubMed] [Google Scholar]
  23. Greene D. A., Mackway A. M. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition. Diabetes. 1986 Oct;35(10):1106–1108. doi: 10.2337/diab.35.10.1106. [DOI] [PubMed] [Google Scholar]
  24. Greene D. A. Metabolic abnormalities in diabetic peripheral nerve: relation to impaired function. Metabolism. 1983 Jul;32(7 Suppl 1):118–123. doi: 10.1016/s0026-0495(83)80024-9. [DOI] [PubMed] [Google Scholar]
  25. Greene D. A., Yagihashi S., Lattimer S. A., Sima A. A. Nerve Na+-K+-ATPase, conduction, and myo-inositol in the insulin-deficient BB rat. Am J Physiol. 1984 Oct;247(4 Pt 1):E534–E539. doi: 10.1152/ajpendo.1984.247.4.E534. [DOI] [PubMed] [Google Scholar]
  26. Hansen S., Ballantyne J. P. Axonal dysfunction in the neuropathy of diabetes mellitus: a quantitative electrophysiological study. J Neurol Neurosurg Psychiatry. 1977 Jun;40(6):555–564. doi: 10.1136/jnnp.40.6.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jakobsen J. Axonal dwindling in early experimental diabetes. I. A study of cross sectioned nerves. Diabetologia. 1976 Dec;12(6):539–546. doi: 10.1007/BF01220629. [DOI] [PubMed] [Google Scholar]
  28. Johnson P. C., Doll S. C., Cromey D. W. Pathogenesis of diabetic neuropathy. Ann Neurol. 1986 May;19(5):450–457. doi: 10.1002/ana.410190505. [DOI] [PubMed] [Google Scholar]
  29. Kimura J., Yamada T., Stevland N. P. Distal slowing of motor nerve conduction velocity in diabetic polyneuropathy. J Neurol Sci. 1979 Jul;42(2):291–302. doi: 10.1016/0022-510x(79)90061-3. [DOI] [PubMed] [Google Scholar]
  30. Mulvany M. J. Vascular effects of altered sodium, potassium pump activity. Scand J Clin Lab Invest Suppl. 1986;180:40–48. [PubMed] [Google Scholar]
  31. Olsson Y., Säve-Söderbergh J., Sourander P., Angervall L. A patho-anatomical study of the central and peripheral nervous system in diabetes of early onset and long duration. Pathol Eur. 1968;3(1):62–79. [PubMed] [Google Scholar]
  32. Reske-Nielsen E., Lundbaek K. Pathological changes in the central and peripheral nervous system of young long-term diabetics. II. The spinal cord and peripheral nerves. Diabetologia. 1968 Jan;4(1):34–43. doi: 10.1007/BF01241031. [DOI] [PubMed] [Google Scholar]
  33. Rosenbluth J. Glial membrane specializations in extraparanodal regions. J Neurocytol. 1978 Dec;7(6):709–719. doi: 10.1007/BF01205146. [DOI] [PubMed] [Google Scholar]
  34. Said G., Slama G., Selva J. Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy. Brain. 1983 Dec;106(Pt 4):791–807. doi: 10.1093/brain/106.4.791. [DOI] [PubMed] [Google Scholar]
  35. Sima A. A., Bouchier M., Christensen H. Axonal atrophy in sensory nerves of the diabetic BB-Wistar rat: a possible early correlate of human diabetic neuropathy. Ann Neurol. 1983 Mar;13(3):264–272. doi: 10.1002/ana.410130307. [DOI] [PubMed] [Google Scholar]
  36. Sima A. A., Brismar T. Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities. Ann Neurol. 1985 Jul;18(1):21–29. doi: 10.1002/ana.410180105. [DOI] [PubMed] [Google Scholar]
  37. Sima A. A. Can the BB-rat help to unravel diabetic neuropathy? Neuropathol Appl Neurobiol. 1985 Jul-Aug;11(4):253–264. doi: 10.1111/j.1365-2990.1985.tb00023.x. [DOI] [PubMed] [Google Scholar]
  38. Sima A. A., Lattimer S. A., Yagihashi S., Greene D. A. Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. J Clin Invest. 1986 Feb;77(2):474–484. doi: 10.1172/JCI112326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sima A. A., Lorusso A. C., Thibert P. Distal symmetric polyneuropathy in the spontaneously diabetic BB-wistar rat. An ultrastructural and teased fiber study. Acta Neuropathol. 1982;58(1):39–47. doi: 10.1007/BF00692696. [DOI] [PubMed] [Google Scholar]
  40. Sima A. A. Peripheral neuropathy in the spontaneously diabetic BB-Wistar-rat. An ultrastructural study. Acta Neuropathol. 1980;51(3):223–227. doi: 10.1007/BF00687389. [DOI] [PubMed] [Google Scholar]
  41. THOMAS P. K., LASCELLES R. G. SCHWANN-CELL ABNORMALITIES IN DIABETIC NEUROPATHY. Lancet. 1965 Jun 26;1(7400):1355–1357. doi: 10.1016/s0140-6736(65)92154-9. [DOI] [PubMed] [Google Scholar]
  42. VIZOSO A. D. The relationship between internodal length and growth in human nerves. J Anat. 1950 Oct;84(4):342–353. [PMC free article] [PubMed] [Google Scholar]
  43. Vizoso A. D., Young J. Z. Internode length and fibre diameter in developing and regenerating nerves. J Anat. 1948 Apr;82(Pt 1-2):110–134.1. [PMC free article] [PubMed] [Google Scholar]
  44. Vracko R. A comparison of the microvascular lesions in diabetes mellitus with those in normal aging. J Am Geriatr Soc. 1982 Mar;30(3):201–205. doi: 10.1111/j.1532-5415.1982.tb01304.x. [DOI] [PubMed] [Google Scholar]
  45. Williams E., Timperley W. R., Ward J. D., Duckworth T. Electron microscopical studies of vessels in diabetic peripheral neuropathy. J Clin Pathol. 1980 May;33(5):462–470. doi: 10.1136/jcp.33.5.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Winegrad A. I., Simmons D. A., Martin D. B. Has one diabetic complication been explained? N Engl J Med. 1983 Jan 20;308(3):152–154. doi: 10.1056/NEJM198301203080309. [DOI] [PubMed] [Google Scholar]
  47. Yagihashi S., Matsunaga M. Ultrastructural pathology of peripheral nerves in patients with diabetic neuropathy. Tohoku J Exp Med. 1979 Dec;129(4):357–366. doi: 10.1620/tjem.129.357. [DOI] [PubMed] [Google Scholar]
  48. Yasuda H., Dyck P. J. Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology. 1987 Jan;37(1):20–28. doi: 10.1212/wnl.37.1.20. [DOI] [PubMed] [Google Scholar]
  49. Yorek M. A., Dunlap J. A., Ginsberg B. H. myo-Inositol metabolism in 41A3 neuroblastoma cells: effects of high glucose and sorbitol levels. J Neurochem. 1987 Jan;48(1):53–61. doi: 10.1111/j.1471-4159.1987.tb13126.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES